Evidence map›Paper›PMID 25946155›Full record

ReviewMemorias do Instituto Oswaldo Cruz2015

Update on oral Chagas disease outbreaks in Venezuela: epidemiological, clinical and diagnostic approaches.

Belkisyolé Alarcón de Noya, Zoraida Díaz-Bello, Cecilia Colmenares, Raiza Ruiz-Guevara, Luciano Mauriello, Arturo Muñoz-Calderón, Oscar Noya

Abstract readReview
In one paragraph

Review in Memorias do Instituto Oswaldo Cruz, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Oral Route Infection byPathogens (Basel, Switzerland) · 2026
    Review
  7. Chagas Disease: An Opportunistic Infection in AIDS.Current infectious disease reports · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. The epidemiology of Chagas disease in the Americas.Lancet regional health. Americas · 2024
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Chagas Disease in Europe.Tropical medicine and infectious disease · 2023
    Review
  18. Current tropical medicine reports · 2023
    Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Belkisyolé Alarcón de NoyaSección de Inmunología, Instituto de Medicina Tropical, Universidad Central de Venezuela, Caracas, Venezuela.
Zoraida Díaz-BelloSección de Inmunología, Instituto de Medicina Tropical, Universidad Central de Venezuela, Caracas, Venezuela.
Cecilia ColmenaresSección de Inmunología, Instituto de Medicina Tropical, Universidad Central de Venezuela, Caracas, Venezuela.
Raiza Ruiz-GuevaraEscuela de Medicina Luís Razetti, Facultad de Medicina, Universidad Central de Venezuela, Caracas, Venezuela.
Luciano MaurielloSección de Inmunología, Instituto de Medicina Tropical, Universidad Central de Venezuela, Caracas, Venezuela.
Arturo Muñoz-CalderónSección de Inmunología, Instituto de Medicina Tropical, Universidad Central de Venezuela, Caracas, Venezuela.
Oscar NoyaSección de Inmunología, Instituto de Medicina Tropical, Universidad Central de Venezuela, Caracas, Venezuela.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Orally transmitted Chagas disease has become a matter of concern due to outbreaks reported in four Latin American countries. Although several mechanisms for orally transmitted Chagas disease transmission have been proposed, food and beverages contaminated with whole infected triatomines or their faeces, which contain metacyclic trypomastigotes of Trypanosoma cruzi, seems to be the primary vehicle. In 2007, the first recognised outbreak of orally transmitted Chagas disease occurred in Venezuela and largest recorded outbreak at that time. Since then, 10 outbreaks (four in Caracas) with 249 cases (73.5% children) and 4% mortality have occurred. The absence of contact with the vector and of traditional cutaneous and Romana's signs, together with a florid spectrum of clinical manifestations during the acute phase, confuse the diagnosis of orally transmitted Chagas disease with other infectious diseases. The simultaneous detection of IgG and IgM by ELISA and the search for parasites in all individuals at risk have been valuable diagnostic tools for detecting acute cases. Follow-up studies regarding the microepidemics primarily affecting children has resulted in 70% infection persistence six years after anti-parasitic treatment. Panstrongylus geniculatus has been the incriminating vector in most cases. As a food-borne disease, this entity requires epidemiological, clinical, diagnostic and therapeutic approaches that differ from those approaches used for traditional direct or cutaneous vector transmission.

Indexed as

Chagas DiseaseDisease OutbreaksHumansVenezuela

Identifiers

PMID25946155
PMCPMC4489475

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.